| Serial Number | 88163086 |
| Word Mark | QUICKSTRIP |
| Filing Date | Sunday, October 21, 2018 |
| Status | 604 - ABANDONED - AFTER INTER-PARTES DECISION |
| Status Date | Friday, August 6, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 3, 2020 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The combined word "QuickStrip" with speed stripes to the left of the letter "Q", the word "Quick" in bold and the word "Strip" underlined. |
| Goods and Services | Consulting in the field of orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the field of orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well being, nicotine and nicotine-polymer complexes; consulting in the field of orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the field of orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the field of orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diptheria, typhoid, meningitis, multiple schlerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration |
| Pseudo Mark | QUICK STRIP |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Friday, August 6, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Rapid Dose Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, Ontario L7N2G4 CA |
| Party Name | Rapid Dose Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, Ontario L7N2G4 CA |
| Event Date | Event Description |
| Friday, August 6, 2021 | ABANDONMENT - AFTER INTER PARTES DECISION |
| Friday, August 6, 2021 | OPPOSITION TERMINATED NO. 999999 |
| Friday, August 6, 2021 | OPPOSITION SUSTAINED NO. 999999 |
| Monday, May 3, 2021 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, November 18, 2020 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, November 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 3, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 14, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 30, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 29, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 29, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 29, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 29, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 18, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 18, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 18, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 5, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 5, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 30, 2020 | ASSIGNED TO LIE |
| Friday, January 24, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 20, 2019 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
| Thursday, November 7, 2019 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Thursday, September 5, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, September 5, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, July 26, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 26, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, July 26, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, July 19, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, June 19, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 28, 2019 | ASSIGNED TO EXAMINER |
| Friday, January 25, 2019 | ASSIGNED TO EXAMINER |
| Friday, November 2, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, November 1, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |